# S. Barbarot

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/s-barbarot/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,394 |
| Field | Dermatology and Skin Diseases |
| h-index | 62 |
| i10-index | 196 |
| Last Known Institution | Institut National de la Recherche Agronomique |
| OpenAlex ID | https://openalex.org/A5042438814 |
| ORCID iD | https://orcid.org/0000-0002-6629-9100 |
| Works | 686 |

## Researcher papers

Showing 12 of 15.

- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic/)
- [Epidemiology of atopic dermatitis in adults: Results from an international survey](https://scholariq.org/papers/epidemiology-of-atopic-dermatitis-in-adults-results-from-an-international-survey/)
- [Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation](https://scholariq.org/papers/revised-diagnostic-criteria-for-neurofibromatosis-type-1-and-legius-syndrome-an/)
- [A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma](https://scholariq.org/papers/a-randomized-controlled-trial-of-oral-propranolol-in-infantile-hemangioma/)
- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic-2/)
- [Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-upadacitinib-vs-dupilumab-in-adults-with-moderate-to/)
- [ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children](https://scholariq.org/papers/etfad-eadv-eczema-task-force-2020-position-paper-on-diagnosis-and-treatment-of/)
- [Atopic dermatitis in the pediatric population](https://scholariq.org/papers/atopic-dermatitis-in-the-pediatric-population/)
- [European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy](https://scholariq.org/papers/european-guideline-euroguiderm-on-atopic-eczema-part-i-systemic-therapy/)
- [ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients](https://scholariq.org/papers/etfad-eadv-eczema-task-force-2015-position-paper-on-diagnosis-and-treatment-of/)
- [European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema – part <scp>II</scp>: non‐systemic treatments and treatment recommendations for special <scp>AE</scp> patient populations](https://scholariq.org/papers/european-guideline-scp-euroguiderm-scp-on-atopic-eczema-part-scp-ii-scp-non/)
- [When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council](https://scholariq.org/papers/when-does-atopic-dermatitis-warrant-systemic-therapy-recommendations-from-an/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)

## Researcher university

- [Institut National de la Recherche Agronomique](https://scholariq.org/institutions/institut-national-de-la-recherche-agronomique/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.